Last reviewed · How we verify
Immune System Activator — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Immune System Activator (Immune System Activator) — H. Lundbeck A/S.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Immune System Activator TARGET | Immune System Activator | H. Lundbeck A/S | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Immune System Activator CI watch — RSS
- Immune System Activator CI watch — Atom
- Immune System Activator CI watch — JSON
- Immune System Activator alone — RSS
Cite this brief
Drug Landscape (2026). Immune System Activator — Competitive Intelligence Brief. https://druglandscape.com/ci/immune-system-activator. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab